How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
RAG/ ├── src/ │ ├── config.py # System parameters │ ├── models.py # LLM / Embedding wrappers (DashScope) │ ├── state.py # AgentState definition │ ├── index_builder.py # RAPTOR index construction & hot ...
Code for my BSc dissertation (University of Exeter, 2026). A ResNet-50 is trained to classify full-field mammograms from the INbreast dataset as low or high probability of malignancy. The method under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results